NCT05782569

Brief Summary

Babies born early (under 34 weeks) are at risk of developing lung problems after birth. A major reason for this is that the lungs are not fully developed (lung immaturity). One of the important components not yet produced by the lungs is the surfactant, which allows premature babies to breathe without much effort. Very often babies born early need some help with their breathing and also need surfactant. Surfactant is administered through a breathing tube which is placed into the baby's airway. It is important that surfactant is administered early after birth when the baby cannot produce it. Early administration of surfactant provides better clinical outcomes. Currently the decision to give surfactant is based on clinical parameters such as the level of oxygen that your baby requires. Current strategy of waiting for the baby to reach certain oxygen level, may delay in administering surfactant. But recent scientific data from other countries suggest that ultrasound of the chest/lungs can predict early which babies would need surfactant. This would help us to administer surfactant earlier and improve their respiratory outcome. In this study, we want to confirm the value of chest/Lung ultrasound (LU) to predict the need for surfactant in UK population. As a part of the study, we will perform early LU and serial LU in the first few days of life. In this current study, LU images will only be recorded and not used for clinical management.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

March 20, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 23, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
Last Updated

March 23, 2023

Status Verified

February 1, 2023

Enrollment Period

11 months

First QC Date

January 25, 2023

Last Update Submit

March 22, 2023

Conditions

Keywords

Babies born under 34 weeksRisk of developing lung problems after birth

Outcome Measures

Primary Outcomes (1)

  • Value of chest/Lung ultrasound (LU) to predict the need for surfactant in preterm population.

    Lung ultrasound scores within the first 3 hours of life to predict the need for 1st Dose of surfactant

    3 hours of age

Eligibility Criteria

Age23 Weeks - 34 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Recruiting the neonatal (Newborn) population. Currently there is no definite way of identifying which infant would need surfactant so this research would study study the value of lung ultrasound in predicting which infant would benefit from surfactant

You may qualify if:

  • Gestational age ≤34 weeks based on last menstrual period or ultrasound dating.
  • Non-invasive respiratory support or low flow oxygen needing neonatal unit admission

You may not qualify if:

  • Received surfactant before first LU (\<3hrs of life).
  • Major congenital malformations including congenital lung disease and congenital heart disease as ascertained by the medical team.
  • Infants receiving delivery room surfactant or required intubation shortly after admission.
  • Infants diagnosed with pneumothorax needing needle or chest tube drainage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Loganathan PK, Meau-Petit V, Bhojnagarwala B, Nair V, Holmes J, Occhipinti A, Montasser M. Serial lung ultrasound in predicting the need for surfactant and respiratory course in preterm infants-multicentre observational study (SLURP). Eur J Pediatr. 2025 May 23;184(6):356. doi: 10.1007/s00431-025-06185-7.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2023

First Posted

March 23, 2023

Study Start

March 20, 2023

Primary Completion

January 31, 2024

Study Completion

January 31, 2024

Last Updated

March 23, 2023

Record last verified: 2023-02